ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
News Medical1d
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Livestrong.com on MSN2d
Phenylephrine for Colds: Why It Doesn’t Work and What You Should Use Instead
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...